Cargando…
A novel strategy for modulation of MDSC to enhance cancer immunotherapy
Myeloid derived suppressor cells (MDSC) suppress anti-tumor immune responses. Our recent publication provides evidence that SHIP-1 plays a prominent role in pancreatic tumor development by regulating MDSC. Therefore, SHIP-1 may be a potential therapeutic target for the treatment of MDSC-related hema...
Autor principal: | Ghansah, Tomar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489768/ https://www.ncbi.nlm.nih.gov/pubmed/23162780 http://dx.doi.org/10.4161/onci.20201 |
Ejemplares similares
-
MIF: metastasis/MDSC-inducing factor?
por: Simpson, Kendra D., et al.
Publicado: (2013) -
Catechins and antitumor immunity: Not MDSC’s cup of tea
por: Santilli, Giorgia, et al.
Publicado: (2013) -
Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression
por: Abrams, Scott I., et al.
Publicado: (2012) -
Of microspheres and microbes: A double-hit strategy for cancer immunotherapy
por: Brinkhoff, Benjamin, et al.
Publicado: (2014) -
Chemokine-enhanced DNA vaccination in cancer immunotherapy
por: Igoucheva, Olga, et al.
Publicado: (2013)